Language selection

Search

Details for: INVEGA

Company: JANSSEN INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02300273INVEGAPALIPERIDONE3 MGTABLET (EXTENDED-RELEASE)ORAL
02300281INVEGAPALIPERIDONE6 MGTABLET (EXTENDED-RELEASE)ORAL
02300303INVEGAPALIPERIDONE9 MGTABLET (EXTENDED-RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: